Adding pembrolizumab to standard neoadjuvant chemoradiotherapy is not associated with increased postoperative complications after esophagectomy in ESCC: a retrospective analysis from a prospective database
{{output}}
Background: The current standard of care for locally advanced esophageal squamous cell carcinoma (ESCC) consists of neoadjuvant chemoradiotherapy (nCRT) followed by curative surgery. Recent single-arm trials have demonstrated tha... ...
